Alendronate Sodium; Cholecalciferol Patent Expiration
Alendronate Sodium; Cholecalciferol is Used for improving bone mass and treating osteoporosis in postmenopausal women and men. It was first introduced by Organon Llc
Alendronate Sodium; Cholecalciferol Patents
Given below is the list of patents protecting Alendronate Sodium; Cholecalciferol, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Fosamax Plus D |
US5994329 (Pediatric) | Method for inhibiting bone resorption |
Jan 17, 2019
(Expired) | Organon Llc |
| Fosamax Plus D | US5994329 | Method for inhibiting bone resorption |
Jul 17, 2018
(Expired) | Organon Llc |
| Fosamax Plus D |
US5358941 (Pediatric) | Dry mix formulation for bisphosphonic acids with lactose |
Jun 02, 2013
(Expired) | Organon Llc |
| Fosamax Plus D |
US5681590 (Pediatric) | Dry mix formulation for bisphosphonic acids |
Jun 02, 2013
(Expired) | Organon Llc |
| Fosamax Plus D |
US6090410 (Pediatric) | Dry mix formulation for bisphosphonic acids |
Jun 02, 2013
(Expired) | Organon Llc |
| Fosamax Plus D | US5358941 | Dry mix formulation for bisphosphonic acids with lactose |
Dec 02, 2012
(Expired) | Organon Llc |
| Fosamax Plus D | US5681590 | Dry mix formulation for bisphosphonic acids |
Dec 02, 2012
(Expired) | Organon Llc |
| Fosamax Plus D | US6090410 | Dry mix formulation for bisphosphonic acids |
Dec 02, 2012
(Expired) | Organon Llc |
Alendronate Sodium; Cholecalciferol's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List